FAQ

FIGO Stage IB2

A FIGO stage term that applies to gynecologic cancers. For cervical cancer, it refers to clinically visible lesions that measure more than 4.0 cm in… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2018
01220002018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
BACKGROUND To compare the treatment outcomes of different treatment modalities for International Federation of Gynecology and… (More)
Is this relevant?
Review
2017
Review
2017
FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
The treatment of cervical cancers according to FIGO staging is well defined. For FIGO stage IB2 or more, chemoradiotherapy… (More)
Is this relevant?
2016
2016
Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2?
AIM To determine the ability of magnetic resonance imaging (MRI) in detecting tumour-free margins from the internal os (IO… (More)
Is this relevant?
2016
2016
Three radiation-induced metachronous pelvic tumors in a patient who underwent radiotherapy for cervical cancer: a case report.
INTRODUCTION Patients treated with radiotherapy are under increased long-term risk of developing radiation-induced tumors. In… (More)
Is this relevant?
Review
2013
Review
2013
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
OBJECTIVE To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical… (More)
  • table 1
  • table 3
  • figure 1
  • table 4
  • figure 3
Is this relevant?
Review
2012
Review
2012
The Comparison of Four Different Treatment Modalities in Bulky Stage Ib and Iia Cervix Cancers
Objective: To compare the effectiveness of four different treatment modalities in International Federation of Gynecology and… (More)
  • table I
  • table II
  • figure 1
  • figure 2
Is this relevant?
Review
2007
Review
2007
Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
Globally, cervical cancer is the second most common cause of cancer-related mortality among women causing approximately 234,000… (More)
Is this relevant?
2000
2000
Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference].
Multiple metachronous primary malignancies are becoming increasingly frequent; however, multiple synchronous primary malignancies… (More)
Is this relevant?